Team:Trieste/parts/9
From 2012.igem.org
Line 25: | Line 25: | ||
It has been found to have additional defensive roles such as regulating the inflammatory response and chemo-attracting cells of the adaptive immune system to wound or infection sites, binding and neutralizing LPS, and promoting re-epthelialization and wound closure. | It has been found to have additional defensive roles such as regulating the inflammatory response and chemo-attracting cells of the adaptive immune system to wound or infection sites, binding and neutralizing LPS, and promoting re-epthelialization and wound closure. | ||
</br> | </br> | ||
- | + | Ref and figures: Ulrich et al., 2006; Ramanculov et al., 2001 | |
</p> | </p> | ||
<h2>Assembly</h2> | <h2>Assembly</h2> | ||
Line 35: | Line 35: | ||
<h2>Looking forward</h2> | <h2>Looking forward</h2> | ||
</br> | </br> | ||
+ | <p>At the beginning, our idea was to use the LL 37 cathelicidin as a toxin, to kill the bacteria from inside. Unfortunately this approach was unsuccessfully as the LL 37 does not kill the bacteria.</br> | ||
+ | </br> | ||
+ | We thought to use the LL 37 in another way, combined with the T4 holin, (BBa_K112000) a small bacteriophage-encoded proteins that accumulate during the period of late-protein synthesis after infection and cause lysis of the host cell at a precise genetically programmed time. </br> | ||
+ | </br> | ||
+ | The rational of this construct is to create a synergic action were the holin creates the pores through which the LL37can reach his target</br> | ||
+ | </p> | ||
<h3><a href="http://partsregistry.org/Part:BBa_K875009"target="_blank">Link to the Registry</a></h3> | <h3><a href="http://partsregistry.org/Part:BBa_K875009"target="_blank">Link to the Registry</a></h3> | ||
</br> | </br> |
Revision as of 12:54, 24 September 2012
BBa_K875009
More
Description
LL-37 is a 37-residue, amphipathic, helical peptide found throughout the body and has been shown to exhibit a broad spectrum of antimicrobial activity.
Assembly
Results
Modelling
Looking forward
At the beginning, our idea was to use the LL 37 cathelicidin as a toxin, to kill the bacteria from inside. Unfortunately this approach was unsuccessfully as the LL 37 does not kill the bacteria. We thought to use the LL 37 in another way, combined with the T4 holin, (BBa_K112000) a small bacteriophage-encoded proteins that accumulate during the period of late-protein synthesis after infection and cause lysis of the host cell at a precise genetically programmed time. The rational of this construct is to create a synergic action were the holin creates the pores through which the LL37can reach his target